Skov BG - Search Results

1

Prognostic impact of histologic demonstration of chromogranin A and neuron specific enolase in pulmonary adenocarcinoma.

Skov BG, Sørensen JB, Hirsch FR, Larsson LI, Hansen HH. Skov BG, et al. Ann Oncol. 1991 May;2(5):355-60. doi: 10.1093/oxfordjournals.annonc.a057955. Ann Oncol. 1991. PMID: 1954180 Free article. Clinical Trial.

2

Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer.

Jørgensen LG, Hirsch FR, Skov BG, Osterlind K, Cooper EH, Larsson LI. Jørgensen LG, et al. Among authors: skov bg. Br J Cancer. 1991 Jan;63(1):151-3. doi: 10.1038/bjc.1991.31. Br J Cancer. 1991. PMID: 1703432 Free PMC article.

3

The prevalence of ALK rearrangement in pulmonary adenocarcinomas in an unselected Caucasian population from a defined catchment area: impact of smoking.

Skov BG, Clementsen P, Larsen KR, Sørensen JB, Mellemgaard A. Skov BG, et al. Histopathology. 2017 May;70(6):889-895. doi: 10.1111/his.13148. Epub 2017 Feb 9. Histopathology. 2017. PMID: 27943404

4

Monoclonal antibodies in the detection of bone marrow metastases in small cell lung cancer.

Skov BG, Hirsch FR, Bobrow L. Skov BG, et al. Br J Cancer. 1992 Apr;65(4):593-6. doi: 10.1038/bjc.1992.120. Br J Cancer. 1992. PMID: 1373295 Free PMC article.

5

Expression of 'small cell carcinoma antigens' in primary small cell lung cancer and metastases: an immunohistochemical study.

Skov BG, Hirsch FR, Hay FG, Olsen JE, Bobrow LG. Skov BG, et al. Br J Cancer Suppl. 1991 Jun;14:46-8. Br J Cancer Suppl. 1991. PMID: 1645571 Free PMC article.

6

ME1-antibody labelling of primary bronchogenic tumours and extrapulmonary malignancies.

Skov BG, Stahel RA, Hirsch F. Skov BG, et al. Lung Cancer. 1994 Sep;11(3-4):221-7. doi: 10.1016/0169-5002(94)90542-8. Lung Cancer. 1994. PMID: 7529122

7

Neuroendocrine characteristics in malignant lung tumors: implications for diagnosis, treatment, and prognosis.

Senderovitz T, Skov BG, Hirsch FR. Senderovitz T, et al. Among authors: skov bg. Cancer Treat Res. 1995;72:143-54. doi: 10.1007/978-1-4615-2630-8_7. Cancer Treat Res. 1995. PMID: 7702985 Review. No abstract available.

8

Are pathologists biased by clinical information?: A blinded cross-over study of the histopathological diagnosis of mesothelial tumours versus pulmonary adenocarcinoma.

Skov BG, Braendstrup O, Hirsch FR, Lauritzen AF, Nielsen HW, Skov T. Skov BG, et al. Among authors: skov t. Lung Cancer. 1994 Dec;11(5-6):365-72. doi: 10.1016/0169-5002(94)92165-2. Lung Cancer. 1994. PMID: 7704493

9

Differentiation of adenocarcinoma of the lung and malignant mesothelioma: predictive value and reproducibility of immunoreactive antibodies.

Skov BG, Lauritzen AF, Hirsch FR, Skov T, Nielsen HW. Skov BG, et al. Among authors: skov t. Histopathology. 1994 Nov;25(5):431-7. doi: 10.1111/j.1365-2559.1994.tb00004.x. Histopathology. 1994. PMID: 7868083

10

The histopathological diagnosis of malignant mesothelioma v. pulmonary adenocarcinoma: reproducibility of the histopathological diagnosis.

Skov BG, Lauritzen AF, Hirsch F, Nielsen HW. Skov BG, et al. Histopathology. 1994 Jun;24(6):553-7. doi: 10.1111/j.1365-2559.1994.tb00575.x. Histopathology. 1994. PMID: 8063283

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters